ADPT Latest Headlines

Analyst Reaffirms Buy on Adaptive Biotechnologies, Lifting Price Target to $25 Amid Strong MRD Momentum and Raised 2026 Guidance

at www.tipranks.com (Thu, 30-Jul 6:16 AM)

Adaptive Biotechnologies Earns Buy Rating as Strong MRD-Driven Revenue Beat and Margin Expansion Support Attractive Risk-Reward

at www.tipranks.com (Thu, 30-Jul 5:55 AM)

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), Humana (HUM) and Teladoc (TDOC)

at www.tipranks.com (Thu, 30-Jul 5:10 AM)

Adaptive Biotechnologies CSO Transitions to Strategic Consulting Role

at www.tipranks.com (Wed, 29-Jul 5:03 PM)

Adaptive Biotechnologies GAAP EPS of -$0.25 misses by $0.12, revenue of $71.55M beats by $6.1M

at seekingalpha.com (Wed, 29-Jul 4:38 PM)

Here are the major earnings after the close Wednesday

at seekingalpha.com (Wed, 29-Jul 10:00 AM)

Adaptive Biotechnologies Q2 2026 Earnings Preview

at seekingalpha.com (Tue, 28-Jul 5:35 PM)

Adaptive Biotechnologies Boosts Flexibility with $300 Million Upsized Convertible Notes Offering

Market Chameleon (Wed, 17-Jun 8:57 AM)